Pre-eclampsia treatment according to scientific evidence;Tratamento da pré-eclâmpsia baseado em evidências

Revista Brasileira de Ginecologia e Obstetricia

Volumn 32, Issue 9, 2010, Pages 459-468

  Neto, Carlos Noronha ^a   de Souza, Alex Sandro Rolland ^a   Amorim, Melania Maria Ramos ^a  

^a INSTITUTO DE MEDICINA INTEGRAL PROF FERNANDO FIGUEIRA   (Brazil)

Author keywords

Pre eclampsia magnesium sulfate methyldopa clinical trials

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; PREECLAMPSIA; PREGNANCY;

ANTIHYPERTENSIVE AGENTS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY;

EID: 79551643499     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Costa AAR, Ribas MSSS, Amorim MMR, Santos LC. Mortalidade materna na cidade do Recife. Rev Bras Ginecol Obstet. 2002;24(7):455-62.
2. Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Am J Obstet Gynecol. 1988;158(1):80-3.
3. Amorim MMR, Katz L, Valença M, Araújo DE. Morbidade maternal grave em UTI obstétrica no Recife, região nordeste do Brasil. Rev Assoc Med Bras. 2008;54(3):261-6.
4. Katz L, Amorim MMR, Miranda GV, Silva JLP. Perfil clínico, laboratorial e complicações de pacientes com síndrome HELLP admitidas em uma unidade de terapia intensiva obstétrica. Rev Bras Ginecol Obstet. 2008;30(2):80-6.
5. Amorim MMR, Katz L, Ávila MB, Araújo DE, Valença M, Albuquerque CJM, et al. Perfil das admissões em uma unidade de terapia intensiva obstétrica de uma maternidade brasileira. Rev Bras Saúde Matern Infant. 2006;6 Suppl 1:S55-62.
6. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(1):S1-22.
7. Redman CW. Immunology of preeclampsia. Semin Perinatol. 1991;15(3):257-62.
8. Serrano Díaz NC, Péz Leal MC, Martínez Linares MP, Casas Romero JP, Gil Urbano L, Navarro Mancilla AA. Bases genéticas y moleculares de la preeclampsia. Med UNAB. 2002;5(15):185-92.
9. Gerretsen G, Huisjes HJ, Hardonk MJ, Elema JD. Trophoblast alterations in the placental bed in relation to physiological changes in spiral arteries. Br J Obstet Gynaecol. 1983;90(1):34-9.
10. Pacheco Romero J. Disfunción endotelial en la preeclampsia. An. Fac Med (Perú). 2003;64(1):43-54.
11. Diagnosis and management of preeclampsia and eclampsia. ACGO Pract Bull. 2002;(33):1-9.
12. de Melo BC, de Amorim MM, Katz L, Coutinho I, Veríssimo G. Uterine artery Doppler in the third trimester of pregnancy and postnatal outcome of patients with severe preeclampsia. Hypertens Pregnancy. 2010;29(2):135-47.
13. Churchill D, Duley L. Interventionist versus expectant care for severe pre-eclampsia before term. Cochrane Database Syst Rev. 2002;(31):CD003106.
14. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;(31):CD004454.
15. Duley L, Williams J, Henderson-Smart DJ. Plasma volume expansion for treatment of pre-eclampsia. Cochrane Database Syst Rev. 2000;(12):CD001805.
16. Meher S, Abalos E, Carroli G. Bed rest with or without hospitalization for hypertension during pregnancy. Cochrane Database Syst Rev. 2005;(14):CD003514.
17. Duley L, Gülmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010;(12):CD000025.
18. Duley L, Henderson-Smart DJ. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2010;(1):CD001449.
19. Brasil. Câmara Técnica de Avaliação de Tecnologias. Metodologia para avaliação de tecnologias. 2001 [citado 2010 Jul 11]. Disponível em:
20. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol. 1994;171(3):818-22.
21. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol. 1990;76(6):1070-5.
22. Haddad B, Deis S, Goffinet F, Paniel BJ, Cabrol D, Siba BM. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation. Am J Obstet Gynecol. 2004;190(6):1590-5.
23. Sibai BM, Barton JR. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol. 2007;196(6):514.e1-9.
24. Souza AS, Amorim MM, Coutinho IC, Lima MM, Noronha Neto C, Figueiroa JN. Effect of the loading dose of magnesium sulfate (MgSO4) on the parameters of Doppler flow velocity in the uterine, umbilical and middle cerebral arteries in severe preeclampsia. Hypertens Pregnancy. 2010;29(2):123-34.
25. Souza ASR, Amorim MMR, Santos RE, Noronha Neto C, Porto AMF. Efeito do sulfato de magnésio sobre o índice de pulsatilidade das artérias uterinas, umbilical e cerebral média fetal de acordo com a persistência da incisura protodiastólica da artéria uterina na pré-eclâmpsia grave. Rev Bras Ginecol Obstet. 2009;31(2):82-8.
26. Souza ASR, Amorim MMR, Coêlho ICN, Lima MMS, Noronha Neto C, Figueroa JN. Doppler das artérias umbilicais e cerebral média fetal após sulfato de magnésio na pré-eclâmpsia. Rev Assoc Med Bras. 2008;54(3):232-7.
27. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev. 2000;(2):CD000065.
28. Amorim MM, Santos LC, Faúndes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol. 1999;180(5):1283-8.
29. Lazard EM. A preliminary report on the intravenous use of magnesium sulphate in puerperal eclampsia. Am J Obstet Gynecol. 1925;9(2):178-88.
30. Pritchard JA. The use of the magnesium ion in the management of eclamptogenic toxemias. Surg Gynecol Obstet. 1955;100(2):131-40.
31. Zuspan FP. Treatment of severe preeclampsia and eclampsia. Clin Obstet Gynecol. 1966;9(4):954-72.
32. Sibai BM, Graham JM, McCubbin JH. A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol. 1984;150(6):728-33.
33. Atallah AN. The Eclampsia trial, a model of international collaborative study with worldwide benefits. Sao Paulo Med J. 1995;113(4):927-8.
34. Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359(9321):1877-90.
35. Yankowitz J. Pharmacologic treatment of hypertensive disorders during pregnancy. J Perinat Neonatal Nurs. 2004;18(3):230-40.
36. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72.
37. Günenç O, Çiçek N, Görkemli H, Celik C, Acar A, Akyürek C. The effect of methyldopa treatment on uterine, umblical and fetal middle cerebral artery blood flows in preeclamptic patients. Arch Gynecol Obstet. 2002;266(3):141-4.
38. Souza AR, Amorim MR, Costa AA, Noronha N.C. Tratamento anti- hipertensivo na gravidez. Acta Med Port. 2010;23(1):77-84.
39. Smith P, Anthony J, Johanson R. Nifedipine in pregnancy. Br J Obstet Gynaecol. 2000;107(3):299-307.
40. Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2010;(1):CD002863.
41. Elhassan EM, Mirghani OA, Habour AB, Adam I. Methyldopa versus no drug treatment in the management of mild pre-eclampsia. East Afr Med J. 2002;79(4):172-5.
42. Vermillion ST, Scardo JA, Newman RB, Chauhan SP. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol. 1999;181(4):858-61.
43. Levin AC, Doering PL, Hatton RC. Use of nifedipine in the hypertensive diseases of pregnancy. Ann Pharmacother. 1994;28(12):1371-8.
44. Aali BS, Nejad SS. Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia. Acta Obstet Gynecol Scand. 2002;81(1):25-30.
45. Collins R, Yusuf S, Peto R. Overview of randomised trials of diuretics in pregnancy. Br Med J (Clin Res Ed). 1985;290(6461):17-23.
46. Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374(9694):979-88.
47. Amorim MM, Katz L, Coutinho I, Souza AS, Scavuzzi A, Santos Filho O, et al. Risk factors for cesarean section in patients with severe preeclampsia. Int J Gynaecol Obstet. 2009;107 Suppl 2:462.
48. Xenakis EM, Piper JM, Field N, Conway D, Langer O. Preeclampsia: is induction of labor more successful? Obstet Gynecol. 1997;89(4):600-3.
49. Nassar AH, Adra AM, Chakhtoura N, Gómez-Marín O, Beydoun S. Severe preeclampsia remote from term: labor induction or elective cesarean delivery? Am J Obstet Gynecol. 1998;179(5):1210-3.
50. ACOG Committee on Obstetric Practice. Committee opinion. Induction of labor for vaginal birth after caesarean delivery. Obstet Gynecol. 2002;99(4):679-80.